Fig. 4
From: Immunotherapy landscape analyses of necroptosis characteristics for breast cancer patients
The prediction efficiency of the NRG signature in patients with different clinical states. A K-M survival curve of the high- and low-risk groups of different ages. B K-M survival curve of the two risk groups in different stages. C K-M survival curve of the two risk groups in different T categories stages. D K-M survival curve of the two risk groups in different N categories stages. E K-M survival curve of the two risk groups in different M categories stages. F Correlations between the risk scores and status